Attruby (acoramidis), a Near Complete TTR Stabilizer (90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
- Attruby is the first and only approved product with a label…
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC”…
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc.…
Globus Medical Launches ExcelsiusHub Navigation System
AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:…
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ:…
World Science Forum 2024 Declaration Calls for Strengthening Trust in Science Globally
BUDAPEST, Hungary, Nov. 23, 2024 (GLOBE NEWSWIRE) -- The 11th World Science…
Webroot Warns Shoppers: AI Convenience Comes with Cybercrime Risk This Holiday Season
A Media Snippet accompanying this announcement is available by clicking on this…
ValueZone: Empowering Global Investors with Secure and Flexible Trading Solutions
New York, NY, Nov. 22, 2024 (GLOBE NEWSWIRE) -- ValueZone, founded in…
VivoPower International PLC Receives Notice from Nasdaq Regarding Compliance with Form 20-F Filing Requirements
Delay in filing form 20F has been due to the significant strategic…
San Francisco’s Black Hammer Brewing Announces Major Expansion, Opens Investment Opportunity to Public
San Francisco, CA , Nov. 22, 2024 (GLOBE NEWSWIRE) -- Black Hammer…